Clinical Trial Update: Intrapartum Sildenafil in Laboring Mothers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intrapartum sildenafil in laboring mothers has been withdrawn, citing conditions such as neonatal asphyxia and intrapartum fetal dist…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrapartum Asphyxia
• Intrapartum Fetal Distress
• Neonatal Asphyxia

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neonatal Asphyxia, Intrapartum Fetal Distress | Phase 3 | Status: WITHDRAWN